Gene therapya s latest benefit: New skin

… Medicine, announced last week. The center, a new joint initiative of Stanford Healthcare, Stanford Children’s Health and the Stanford School of Medicine, is designed to accelerate cellular therapies at the university’s state-of-the-art manufacturing …

New MIP system for therapeutic gene delivery can enhance transgene expression using AAV vector

Advanced engineering of a mini-intronic plasmid system designed to carry a therapeutic gene can significantly enhance the expression of the transgene delivered using an adeno-associated viral vector. The ability to increase transgene expression by up to 40 to 100-fold, which would reduce the cost of manufacturing and perhaps also lessen the immune response of AAV/MIP-based gene therapy, is reported in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.